These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 7533414

  • 1. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy.
    Orosz CG, Bergese SD, Huang EH, Vanbuskirk AM.
    Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414
    [No Abstract] [Full Text] [Related]

  • 2. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG, Huang EH, Bergese SD, Sedmak DD, Birmingham DJ, Ohye RG, VanBuskirk AM.
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [Abstract] [Full Text] [Related]

  • 3. Monoclonal antibody to anti-VCAM-1 interferes with murine cardiac allograft rejection.
    Pelletier R, Ohye R, Kincade P, Ferguson R, Orosz C.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):839-41. PubMed ID: 7679845
    [No Abstract] [Full Text] [Related]

  • 4. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
    Jendrisak M, Jendrisak G, Gamero J, Mohanakumar T.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914
    [No Abstract] [Full Text] [Related]

  • 5. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
    Isobe M, Suzuki J, Yagita H, Okumura K, Sekiguchi M.
    Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478
    [No Abstract] [Full Text] [Related]

  • 6. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation.
    Pearson TC, Hamano K, Morris PJ, Wood KJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480
    [No Abstract] [Full Text] [Related]

  • 7. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
    Hamano K, Morris PJ, Wood KJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
    [No Abstract] [Full Text] [Related]

  • 8. Functional analysis of donor-reactive T cells infiltrating heterotopic cardiac transplants: effect of anti-CD4 MAb in vivo.
    Bishop DK, Shelby J, Eichwald EJ.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):287-9. PubMed ID: 1990534
    [No Abstract] [Full Text] [Related]

  • 9. Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation.
    Isobe M, Ihara A.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1079-80. PubMed ID: 8095106
    [No Abstract] [Full Text] [Related]

  • 10. Prolongation of rat cardiac allograft survival by a monoclonal antibody: anti-rat intercellular adhesion molecule-1.
    Kobayashi H, Miyano T, Yamataka A, Yamataka T, Yagita H, Eto H, Ligo Y, Tansyo S, Kojima Y, Tamatani T.
    Cardiovasc Surg; 1993 Oct; 1(5):577-82. PubMed ID: 7915626
    [Abstract] [Full Text] [Related]

  • 11. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody.
    Orosz CG, Wakely E, Sedmak DD, Bergese SD, VanBuskirk AM.
    Transplantation; 1997 Apr 27; 63(8):1109-17. PubMed ID: 9133472
    [Abstract] [Full Text] [Related]

  • 12. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
    Chen Z, Cobbold S, Waldmann H, Metcalfe S.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):790-1. PubMed ID: 8438482
    [No Abstract] [Full Text] [Related]

  • 13. A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts.
    Nakakura EK, McCabe SM, Zheng B, Shorthouse RA, Scheiner TM, Blank G, Jardieu PM, Morris RE.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):809-12. PubMed ID: 8438493
    [No Abstract] [Full Text] [Related]

  • 14. Combined CTLA4Ig and anti-CD4/DC8 monoclonal antibody treatment prolongs survival of rat-to-mouse heterotopic cardiac xenografts.
    Rehman A, Tu Y, Flye MW.
    Transplant Proc; 1996 Apr 27; 28(2):660-1. PubMed ID: 8623331
    [No Abstract] [Full Text] [Related]

  • 15. Potent CD8+ CTLs detected in anti-CD4 (OKT4A) MAb immunosuppressed cynomolgus recipients with prolonged allograft survival.
    Wee S, Kawai T, Knowles R, Colvin R, Cosimi AB.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):794-5. PubMed ID: 8438484
    [No Abstract] [Full Text] [Related]

  • 16. Graft endothelial VCAM-1 is not necessary for acute cardiac allograft rejection in mice.
    Bergese SD, Pelletier RP, Ferguson RM, Orosz CG.
    Transplant Proc; 1995 Feb 27; 27(1):480-1. PubMed ID: 7533417
    [No Abstract] [Full Text] [Related]

  • 17. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR, Zhan Y, Murray-Segal LJ, Brady JL, Lew AM, Mottram PL.
    Transplantation; 2000 Jul 15; 70(1):168-74. PubMed ID: 10919596
    [Abstract] [Full Text] [Related]

  • 18. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ, Gill RG, Gelhaus HC, Doan AN, Sleater ML, Pietra BA.
    J Heart Lung Transplant; 2005 Sep 15; 24(9):1410-4. PubMed ID: 16143264
    [Abstract] [Full Text] [Related]

  • 19. Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.
    Chavin KD, Qin L, Lin J, Kaplan AJ, Bromberg JS.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):823-4. PubMed ID: 8094913
    [No Abstract] [Full Text] [Related]

  • 20. Microchimerism and graft acceptance: IV. Cardiac allograft acceptance following anti-adhesion molecule antibody therapy.
    Suzuki H, Hara MH, Miyahara T, Tanigawa M, Matsuzaki Y, Onitsuka T, Shibata K, Koga Y, Yamashita A, Miyamoto M, Suzuki S, Amemiya H, Iwaya M, Miyasaka M, Kimura H.
    Transplant Proc; 1996 Aug 15; 28(4):2058-60. PubMed ID: 8769155
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.